Reactive Biosciences Inc.
PrivateLast Round
Debt
Jun 12, 2023
Total Funding Raised
$37.5M
Company Overview
Reactive Biosciences Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Debt round in June 2023.
Reactive Biosciences Inc. is a biotechnology company that develops boron-based medicines using a proprietary discovery platform to target diseases that have been historically difficult to treat.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reactive Biosciences Inc. Comparables
Compare Reactive Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxima | 75% | |
| Borotherapeutics Ltd. | 74% | |
| AN2 Therapeutics | 69% |
For institutional investors. Book with your work email.
Reactive Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 12, 2023 | ||||
| Series A | Sep 12, 2022 | ||||
| Series A | Mar 2, 2017 |
For institutional investors. Book with your work email.
Reactive Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A. M. Pappas & Associates | Series A |
| Hatteras Venture Partners | Series A |
| Gates Foundation | Series A |
| ARCH Venture Partners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
| Elanco | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 142% MoM, from 66 to 160.
- Nov 7, 2024
Monthly visitors increased 107% MoM.
For institutional investors. Book with your work email.
Reactive Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reactive Biosciences Inc.'s valuation, stock price, and market status.
Is Reactive Biosciences Inc. a public or private company?
Reactive Biosciences Inc. is a private company.
What is the current stock price of Reactive Biosciences Inc.?
Reactive Biosciences Inc. is a private company, so its shares have no public market price. Caplight tracks Reactive Biosciences Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reactive Biosciences Inc. worth (valuation)?
Valuation information for Reactive Biosciences Inc. is not publicly available.
Can I buy Reactive Biosciences Inc. stock?
Reactive Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reactive Biosciences Inc.'s last funding round?
Reactive Biosciences Inc.'s most recent funding round was Debt on June 12, 2023.
Who are the main investors in Reactive Biosciences Inc.?
Key investors in Reactive Biosciences Inc. include AgTech Accelerator Corp..
Will Reactive Biosciences Inc. IPO soon?
No public IPO plans have been announced for Reactive Biosciences Inc..
How can I track Reactive Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Reactive Biosciences Inc.'s shares on secondary markets.